3UK Prospective Diabetes Study group: Tight blood pressure and risk of macro vascular complications in type2 diabetes:UKPDS 38. BMJ, 1998,317(7160) :703-713.
4Hansson L, Zanchett: A, Garruthers, SSG, et al. For the HOT Study group:Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) randomized trial. Lancet, 1998,351 (9118):1755-1762.
5Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular outcomes in people with diabetes mellitus:results of the HOPE study and MICRO-HOPE and MICRO-HOPE Sub study Lancet,2000,355(9200) :253-259.
6LeoN,JanL,Thomas H,et al. For the CAPPP study group. Reduced car diovascular morbidity and mortality in hypertension diabetic patients on first-line therapy with and ACE inhibitor compared with a diuretic/βblocker based treatment regimen. Diabetes Care, 2001,24 ( 12 ): 2091-2096.
7Bjorn D,Richard BD,Severre EK,et al. For the LIFE study group. Cardiovascular morbility and mort ality in the Losartan intervention for endpoint reduction in hypertention study(LIFE) :a randomized trial against atenolol. Lancet ,2002,359 ( 9311 ) :995-1003.
8Alkharouf J, Nalinikumari K, Cony D, et al. Long-term effects of the angiotension converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus. Am J Hypertens, 1993, 6 (SPt1) :337-343.
9Wakisaka M,Yoshinari M, Nakamura S, et al. Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal percytes. Microvasc Res, 1999,58 (3): 215 -223.
10Haithcock D ,Jiao H, Cuixl, et al. Renal proximal tubular AT2 receptor:signaling and transport. J Am Soc Nephrol, 1999,11 (suppl): S69-S74.
